Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. (Q48019587)

7 February 2018

meta-analysis

0 references

title

Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. (English)

1 reference

7 February 2018

Helicobacter pylori infectious disease

main subject

Helicobacter pylori

0 references

meta-analysis

0 references

1 reference

Huang JQ

1

1 reference

7 February 2018

Sridhar S

series ordinal

2

1 reference

7 February 2018

Chen Y

series ordinal

3

1 reference

7 February 2018

Hunt RH

series ordinal

4

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

7 February 2018

published in

Gastroenterology

1 reference

7 February 2018

volume

114

1 reference

7 February 2018

issue

6

1 reference

7 February 2018

page(s)

1169-1179

1 reference

7 February 2018

Estimates of the worldwide incidence of eighteen major cancers in 1985.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

The geography of cancer of the stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori infection and the risk of gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

H pylori and gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori serology in patients with gastric carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

An apparent lack of association betweenHelicobacter pylori infection and risk of gastric cancer in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Possible role of Helicobacter pylori infection in early gastric cancer development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Gastric adenocarcinoma and Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori infection and chronic gastritis in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Quantitative methods in the review of epidemiologic literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Guidelines for application of meta-analysis in environmental epidemiology. ISLI Risk Science Institute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Serological response to Helicobacter pylori in gastric and non-gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Guidelines for reading case-control studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Invited commentary: a critical look at some popular meta-analytic methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Invited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Is Helicobacter pylori infection a real risk factor for gastric carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori and gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Selection of controls in case-control studies. I. Principles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

The "case-control" study: valid selection of subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori in promotion of gastric carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori and atrophic gastritis: importance of the cagA status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

The decline in gastric cancer: epidemiology of an unplanned triumph

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Gastric cancer and Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Detection of Helicobacter pylori infection in early stage gastric cancer. A comparison between intestinal- and diffuse-type gastric adenocarcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Prevalence of Helicobacter pylori infection in subtypes of gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori infection--a common worldwide environmental risk factor for gastric cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Helicobacter pylori and early gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

The risk of stomach cancer in patients with gastric or duodenal ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970422-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(98)70422-6

1 reference

7 February 2018

release_tvdg6kr7anfafmnpk7t3krn7zm

Fatcat ID

0 references

PubMed ID

9609753

1 reference

7 February 2018